Concerning innovation and cooperation in the biotechnology industry, the latest statement from the State-owned Assets Supervision and Administration Commission of the State Council.

On March 27, Li Zhen, Deputy Director of the State-owned Assets Supervision and Administration Commission of the State Council, comprehensively introduced the remarkable achievements in technology innovation of central enterprises at the "Enterprise Discovery and Invention Forum" of the 2026 Zhongguancun Forum Annual Meeting. He focused on the new round of technological revolution and industrial transformation in the field of biotechnology and bio-manufacturing, and put forward three cooperation initiatives to global innovation forces to help develop new productive forces and promote high-quality development. Firstly, strengthen original innovation together to build a solid technological foundation for the deep integration of technology innovation and industrial innovation. State-owned central enterprises are willing to explore uncharted territories in technology innovation with global innovative forces, condense basic scientific problems in the development of the bio-manufacturing industry and engineering practice, strengthen basic research and positive research and development, jointly conduct fundamental and cutting-edge common technology research in the field of biotechnology, and solve health problems, resource bottlenecks, and environmental crises faced by humans with high-quality technology supply. Secondly, jointly play a leading role and grasp the core key of deep integration of technology innovation and industrial innovation. Thirdly, jointly promote the transformation of results and open up the implementation path of deep integration of technology innovation and industrial innovation. State-owned central enterprises are willing to actively connect with the demand for transformation with global innovative forces, jointly build transformation platforms, accelerate the improvement of transformation mechanisms, better leverage the advantages of market scale and application scenarios, accelerate technology application and iterative upgrades, and let more achievements in biotechnology move from the laboratory to the production line, transforming into the real productive forces of the bio-industry, creating incremental markets for the global economy, and providing development opportunities.